PB-095Purity on request
CJC-1295 (DAC Modification)
C₁₅₂H₂₅₂N₄₄O₄₂
Long-acting, albumin-binding GHRH analog. DAC-modified 30-mer.
Research Use Only · Endocrine & Cell Repair Research Peptides
CAS 863288-34-0
Docs Documentation Available Upon Request
PB-102Purity on request
Fig. · White to off-white lyophilized powder
Endocrine & Cell Repair Research Peptides
HGH Fragment 176-191
C₇₈H₁₂₃N₂₃O₂₃ · 1815.08 g/mol
HGH Fragment 176-191 is the C-terminal lipolytic domain of human growth hormone (residues 176–191), engineered to isolate hGH's fat-metabolizing activity from its growth-promoting and IGF-1 effects. It is studied as a targeted probe for adipocyte lipolysis and obesity-related research.
The source monograph gives this product the same formula and sequence as AOD9604, distinguishing the two only by AOD9604's added N-terminal tyrosine substitution. Verify against the supplier's COA before treating the two as fully interchangeable.
Purity
On request
Quantity
Milligram, gram, or bulk quantities
Documentation
COA, HPLC, MS / LC-MS, SDS
Packaging
Bulk, non-branded, or private label
Research Use Only · Buyer verification required
Specifications
Technical profile.
Catalog Number
PB-102
CAS Number
66004-57-7
Sequence
H-Tyr-Leu-Gly-Ser-Val-Phe-Thr-Glu-Leu-Ser-Arg-Leu-Phe-Ala-Asn-Leu-Val-Tyr-NH2
Molecular Formula
C₇₈H₁₂₃N₂₃O₂₃
Molecular Weight
1815.08 g/mol
Purity (HPLC)
Available specifications confirmed with quotation
Appearance
White to off-white lyophilized powder
Vial Size
Confirmed with quotation
Storage
−20 °C (long-term) or 2–8 °C (working stock), sealed, desiccated, protected from light
Reconstitution
Water, bacteriostatic water, PBS, or dilute acetic acid buffer
Classification
Research Use Only
Documentation & Quality
What documentation may be available for HGH Fragment 176-191.
HGH Fragment 176-191·PB-102
Certificate of Analysis (COA)
Manufacturing partner or independent summary of identity, purity, and other release testing for a batch.
Pending Verified Documentation
HPLC Chromatogram
Chromatographic data supporting the purity result reported for a batch.
Pending Verified Documentation
Mass Spectrometry (MS) Report
Mass spectrometry data supporting molecular identity confirmation.
Pending Verified Documentation
Endotoxin Test
Endotoxin testing result, where applicable to the product and its intended use.
Pending Verified Documentation
Safety Data Sheet (SDS)
Handling, storage, and safety information for the material.
Pending Verified Documentation
Third-Party Laboratory Report
Testing performed by an independent laboratory, separate from the manufacturing partner's own QC.
Pending Verified Documentation
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Inquire about pricing and availability.
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Related compounds.
View full catalogPB-096Purity on request
Sermorelin
C₁₄₉H₂₄₆N₄₄O₄₂S
N-terminal 1–29 fragment of human GHRH. Shortest fully active form.
Research Use Only · Endocrine & Cell Repair Research Peptides
CAS 86168-78-7
Docs Documentation Available Upon Request
PB-097Purity on request
Tesamorelin
C₂₂₁H₃₆₆N₇₂O₆₇S
44-mer GHRH(1-44) analog with N-terminal hexenoyl cap.
Research Use Only · Endocrine & Cell Repair Research Peptides
CAS 218949-48-5
Docs Documentation Available Upon Request